Ownership history in BARCLAYS PLC · 13 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in VISTAGEN THERAPEUTICS INC (VTGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1 | -19,260 | -100.0% | 0.00% | $4 | $3.55 |
| 2024 Q2 | REDUCED | 19,261 | -3,816 | -16.5% | 0.00% | $67K | $3.48 |
| 2024 Q1 | UNCHANGED | 23,077 | — | 0% | 0.00% | $122K | $5.28 |
| 2023 Q4 | REDUCED | 23,077 | -82,051 | -78.0% | 0.00% | $119K | $5.14 |
| 2023 Q1 | ADDED | 105,128 | +49,562 | +89.2% | 0.00% | $13K | $3.60 |
| 2022 Q4 | ADDED | 55,566 | +47,310 | +573.0% | 0.00% | $6K | $3.00 |
| 2022 Q3 | REDUCED | 8,256 | -1,518 | -15.5% | 0.00% | $1K | $4.50 |
| 2022 Q2 | REDUCED | 9,774 | -21,724 | -69.0% | 0.00% | $9K | $26.40 |
| 2022 Q1 | REDUCED | 31,498 | -204,015 | -86.6% | 0.00% | $40K | $37.20 |
| 2021 Q4 | ADDED | 235,513 | +156,117 | +196.6% | 0.00% | $459K | $58.50 |
As of 2025 Q4 — sorted by position size